Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Total 13F shares
-
67,505,257
-
Share change
-
+581,184
-
Total reported value
-
$10,146,035,323
-
Put/Call ratio
-
20%
-
Price per share
-
$150.33
-
Number of holders
-
434
-
Value change
-
+$89,925,160
-
Number of buys
-
211
-
Number of sells
-
175
Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2019
As of 31 Dec 2019,
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) was held by
434 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,505,257 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, STATE STREET CORP, Neuberger Berman Group LLC, BAMCO INC /NY/, Capital Research Global Investors, JPMORGAN CHASE & CO, and WCM INVESTMENT MANAGEMENT, LLC.
This page lists
437
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.